Saqib Islam
CIK 1575408 · Chief Executive Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.1K
Companies
4
Total Filings
54
Lifetime Open-Market Net
-$31.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | — | $5.67 | — | $0 | 4 | 2026-06-26 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Executive Officer | 0 | $46.99 | $0 | -$31.21M | 25 | 2025-07-02 |
| PASG | Director | 250 | $4.57 | $1.1K | $90.0K | 7 | 2025-05-30 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
Recent Filings · Page 2 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +74,834 | $0 | EDGAR |
| 2025-01-07 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −38,700 | -$1.49M | EDGAR |
| 2024-12-04 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −49,000 | -$2.03M | EDGAR |
| 2024-09-04 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −49,000 | -$1.99M | EDGAR |
| 2024-09-03 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Notice (144) | −146,000 | -$6.07M | EDGAR |
| 2024-06-24 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −49,000 | -$1.96M | EDGAR |
| 2024-06-03 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Notice (144) | −49,000 | -$2.03M | EDGAR |
| 2024-05-23 | PASG | Grant (A) | — | $0 | EDGAR |
| 2024-01-08 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +57,211 | -$1.23M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.